|
|
|
|
| Stage at admission to BC: IVB, recurrent | BC. July 29, 2011 PB, sunitinib, dasatinib, irinotecan |
|
| Regional radiology CT December 17, 2011 | PD | 503 | 187 | VEGF- elevated (blood), EPHA2, c-Kit, PDGFRA/B-over- expressed (tissue- Caris) |
| 9 | Regional hospital June 20, 2011 | APO | Regional medical center CT March 7, 2011 | Tumor in the uncinate process of the pancreas | Stent placement November 30, 2010 |
|
|
|
|
|
|
|
|
|
|
|
|
| Sphincterotomy and papillotomy March 2, 2011 |
|
|
|
|
|
|
|
|
|
|
| Regional medical center CT May 5, 2011 | Liver and lymph node metastases. | Gemcitabine April to May 2011 | Regional radiology CT September 2, 2011 | Recurrence |
|
|
|
|
|
|
|
|
|
| Stage at admission to BC: IVB, recurrent | BC. August 30, 2011 PB, erlotinib, oxaliplatin, capecitabine |
|
| Regional radiology CT January 9, 2012 | SD | 509 | 333 | Negative (blood and tissue- Caris) |
| 10 | Regional hospital June 21, 2011 | APMD | Regional hospital CT June 7, 2011 | Mass in the pancreatic head and body, multiple metastases to the lungs and lymph nodes | Phase I study: gemcitabine and SOM230 June-August 2011 | Regional radiology PET/CT August 30, 2011 | Recurrence |
|
|
|
|
|
|
|
|
|
| Stage at admission to BC: IVB, recurrent | BC. August 27, 2011 PB, pazopanib, erlotinib, dasatinib, gemcitabine |
|
| Regional radiology CT December 5, 2011 | SD | 492 | 425 | VEGF- elevated (blood) Negative, (tissue- Caris) |
| 11 | Regional hospital May 31, 2011 | APMD | Regional radiology CT June 6, 2011 | Mass in the pancreatic head | Stent placement March 18, 2011 |
|
|
|
|
|
|
|
|
|
|
|
|
| Aborted Whipple procedure. Palliative bypass April 28, 2011 |
|
|
|
|
|
|
|
|
|
|
|
|
| FOLFIRINOX x3 June 20, 2011- September 27, 2011 | Regional radiology CT September 27, 2011 | Persistent disease |
|
|
|
|
|